Dopamine is a catecholamine indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output. It is available as injection for intravenous use. MedsAcross supplies Dopamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Dopamine HCl Injection is indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output. Dopamine HCl Injection is a catecholamine indicated to improve hemodynamic status in patients in shock.
Source: US FDA prescribing information
Dopamine is a natural catecholamine formed by the decarboxylation of 3,4 dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine elicits its pharmacological action by activating dopamine D1 and D2 receptors, beta 1 receptors and alpha 1 receptors. The activation of different receptors leading to its effects are dependent on dopamine dose.
Source: US FDA prescribing information
Correct hypovolemia, acidosis, and hypoxia prior to use. Administer in a large vein with an infusion pump preferably in an intensive care setting. Recommended starting dosage in adults and pediatric patients is 2 to 5 mcg/kg/minute as a continuous intravenous infusion. Titrate in 5 to 10 mcg/kg/minute increments based on hemodynamic response and tolerability, up to not more than 50 mcg/kg/minute. See the Full Prescribing Information for important preparation instructions and drug incompatibilities.
Source: US FDA prescribing information
Dopamine is contraindicated in patients with pheochromocytoma.
Source: US FDA prescribing information
• Tissue ischemia: Severe peripheral and visceral vasoconstriction can occur. Address hypovolemia prior to use, monitor extremities, and infuse into large vein. • Cardiac arrhythmias: Monitor closely. • Hypotension after abrupt discontinuation: Gradually reduce infusion rate while expanding blood volume with intravenous fluids. • Severe hypersensitivity reactions due to sodium metabisulfite excipient: May cause anaphylaxis including life‑threatening or less severe asthmatic episodes in susceptible individuals.
Source: US FDA prescribing information
The following adverse reactions are described elsewhere in the labeling: • Tissue Ischemia • Cardiac Arrhythmias • Hypotension • Severe Hypersensitivity Reactions The following adverse reactions have been identified during postapproval use of dopamine. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Cardiac Disorders: anginal pain, palpitation Gastrointestinal Disorders: nausea, vomiting Metabolism and Nutrition Disorders: azotemia Nervous System Disorders: headache, anxiety Respiratory Disorders: dyspnea Skin and Subcutaneous Tissue Disorders: piloerection Vascular Disorders: hypertension The most common adverse reaction is localized vasoconstriction due to extravasation.
Source: US FDA prescribing information
See Table 1 for clinically significant drug interactions with dopamine. Table 1: Clinically Significant Drug Interactions with Dopamine Halogenated Anesthetics Clinical Impact: Concomitant use may increase cardiac autonomic irritability and can sensitize the myocardium to the action of dopamine which may lead to ventricular arrhythmias and hypertension. Intervention: Monitor cardiac rhythm. Examples: desflurane, enflurane, isoflurane, and sevoflurane. MAO Inhibitors Clinical Impact: Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine which may result in severe hypertension and cardiac arrhythmia.
Source: US FDA prescribing information
Store at 20°C to 25°C (68°F to 77°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
9 presentations of Dopamine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Dopamine 200 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 400 mg/10 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 400 mg/250 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 800 mg/250 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 800 mg/500 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 200 mg/250 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 400 mg/5 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 400 mg/500 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Dopamine 800 mg/10 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions linked to Dopamine in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 9 presentations of Dopamine and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Dopamine on 25 February 1974, according to Drugs@FDA.
Yes. Dopamine has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
No listed presentation of Dopamine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Dopamine is classified under ATC code C01CA04 (Dopamine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.